Leukodepletion filters reduce <i>Leishmania</i> in blood products when used at collection or at the bedside

Abstract

Filtration at the time of collection and after storage of Leishmania-infected blood resulted in a substantial reduction of free and intracellular organisms. There is currently no donor screen for Leishmania. Until adequate testing is developed, the use of leukodepletion filters could add to the safety of the blood supply.